New Clinical Trial Partners to Expand Laboratory Sciences Clinical Sample Analysis Groups - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

New Clinical Trial Partners to Expand Laboratory Sciences Clinical Sample Analysis Groups



Charles River has established partnerships with Target Health Inc. and Theorem Clinical Research Inc. allow nonclinical testing programs performed by Charles River in bioanalysis, immunogenicity, and immunology to transition to support clinical trials.

Charles River develops and validates assays in support of nonclinical programs. Many of these assays can be transferred and validated for human matrix and subsequently used for analyzing clinical samples.

In a statement, the Charles River reports that these new relationships will allow company scientists to manage clinical sample analysis using defined processes and procedures to improve customer satisfaction.

http://www.criver.com

 

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
29%
Oversee medical treatment of patients in the US.
11%
Provide treatment for patients globally.
7%
All of the above.
46%
No government involvement in patient treatment or drug development.
7%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality
FDA Readies Quality Metrics Measures
New FDA Team to Spur Modern Drug Manufacturing
From Generics to Supergenerics

Click here